isophthalate has been researched along with Alzheimer Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiltunen, M; Jäntti, M; Mäkinen, P; Natunen, T; Paldanius, KMA; Sarajärvi, T; Talman, V; Tarvainen, I; Tuominen, RK; Wu, JC | 1 |
| Al-Qawasmeh, R; Al-Tel, TH; Odeh, RA; Tarazi, H; Voelter, W; Yousef, IA | 1 |
| Li, J; Li, JY; Ma, LP; Shen, JK; Wang, X; Xiao, K; Xiong, B; Yu, HP; Zhang, HY; Zhu, YP | 1 |
3 other study(ies) available for isophthalate and Alzheimer Disease
| Article | Year |
|---|---|
Protein kinase C -activating isophthalate derivatives mitigate Alzheimer's disease-related cellular alterations.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Bryostatins; Cell Line, Tumor; Cell Survival; Coculture Techniques; Dendritic Spines; Enzyme Activators; Hippocampus; Humans; Mice; Microglia; Neurons; Nitric Oxide; Peptide Fragments; Phthalic Acids; Primary Cell Culture; Tumor Necrosis Factor-alpha | 2018 |
Design, synthesis and SAR analysis of potent BACE1 inhibitors: Possible lead drug candidates for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Cell Line; Drug Design; Enzyme Inhibitors; Humans; Imidazoles; Molecular Docking Simulation; Phthalic Acids; Structure-Activity Relationship | 2017 |
Discovery of potent beta-secretase (bace-1) inhibitors by the synthesis of isophthalamide-containing hybrids.
Topics: Alzheimer Disease; Amides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Computer Simulation; Drug Design; Humans; Isoenzymes; Models, Molecular; Molecular Structure; Phthalic Acids; Protease Inhibitors; Protein Conformation; Structure-Activity Relationship; Sulfonamides; Valine | 2009 |